Nanobiotix (NASDAQ:NBTX) a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, provided an...
By Sam Boughedda Investing.com — Biotechnology company Nanobiotix (NASDAQ:NBTX) shares rallied 23% on Thursday after it revealed after Wednesday's closing bell that it has enrolled...